Skip to main content
Log in

Behavior of Iron and Ferritin After Bariatric Surgery in Patients With and Without Hepatic Steatosis

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Iron deficiency and hepatic steatosis are common in bariatric surgery patients. Steatosis can falsely elevate ferritin values even in presence of iron deficiency. This study aims to assess the influence of hepatic steatosis on iron deficiency and replacement therapy after bariatric surgery.

Methods

Seventy-nine individuals undergoing gastric bypass have been studied at 4 time points (preoperative and 1, 3, and 6 months after surgery). Weight, body mass index (BMI), iron, ferritin, vitamin B12, folate, hemoglobin, gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and use of iron replacement were recorded.

Results

Forty-two individuals (53%) had moderate/severe steatosis assessed by ultrasound. No differences were seen in iron profile and replacement therapy features compared to individuals with no/mild steatosis both in the preoperative and postoperative periods. Mixed model analysis showed ferritin levels to be higher in the moderate/severe steatosis group than in no/mild steatosis at the 6th month (139 ± 131 vs. 60.9 ± 49.8, p < 0.05). Values in both groups were lower than baseline, with p < 0.0001. The same was observed with serum iron (92.1 ± 39.6 moderate/severe steatosis vs. 68.6 ± 33.4 no/mild steatosis, p < 0.001; p from baseline < 0.01 for both). GGT was higher in moderate/severe steatosis in the 3rd month (38.8 ± 40.5 vs. 28.8 ± 20.8, p < 0.05; p from baseline < 0.0001 for both).

Conclusions

Ferritin levels were consistently higher in individuals with steatosis in the follow-up of bariatric surgery, but no apparent implication on the diagnosis of iron deficiency and in the prescription of replacement therapy was demonstrated at 6 months of follow-up. Longer studies are probably necessary to investigate this matter.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288–98.

    Article  Google Scholar 

  2. Tremmel M, Gerdtham U-G, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Pu. 2017;14:435.

    Article  Google Scholar 

  3. O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29:3–14.

    Article  Google Scholar 

  4. Young MT, Gebhart A, Phelan MJ, Nguyen NT. Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surgeons. 2015;220:880–5.

    Article  Google Scholar 

  5. Borisenko O, Colpan Z, Dillemans B, Funch-Jensen P, Hedenbro J, Ahmed AR. Clinical indications, utilization, and funding of bariatric surgery in Europe. Obes Surg. 2015;25:1408–16.

    Article  Google Scholar 

  6. Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012;8:544–56.

    Article  CAS  Google Scholar 

  7. Barr J, Caballería J, Martínez-Arranz I, Domínguez-Díez A, Alonso C, Muntané J, et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res. 2012;11:2521–32.

    Article  CAS  Google Scholar 

  8. Pontiroli AE, Benetti A, Folini L, Merlotti C, Frigè F. Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. Nutr Hosp. 2013;28(Suppl 2):104–8.

    CAS  PubMed  Google Scholar 

  9. Kheniser KG, Kashyap SR, Schauer PR, Lam ETC, Kullman ES. Prevalence of anemia in subjects randomized into roux-en-Y gastric bypass or sleeve gastrectomy. Obes Surg. 2017;27:1381–6.

    Article  Google Scholar 

  10. Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55:77–85.

    Article  CAS  Google Scholar 

  11. Jung JY, Shim J-J, Park SK, Ryoo J-H, Choi J-M, Oh I-H, et al. Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population. Hepatol Int. 2019;13:222–33.

    Article  Google Scholar 

  12. Krzizek E-C, Brix JM, Stöckl A, Parzer V, Ludvik B. Prevalence of Micronutrient Deficiency after Bariatric Surgery. Obes Facts. 2021;14:197–204.

    Article  CAS  Google Scholar 

  13. Steenackers N, der Schueren BV, Mertens A, Lannoo M, Grauwet T, Augustijns P, et al. Iron deficiency after bariatric surgery: what is the real problem? P Nutr Soc. 2018;77:445–55.

    Article  Google Scholar 

  14. Lewis C-A, de Jersey S, Seymour M, Hopkins G, Hickman I, Osland E. Iron, vitamin B12, folate and copper deficiency after bariatric surgery and the impact on anaemia: a systematic review. Obes Surg. 2020;30:4542–91.

    Article  Google Scholar 

  15. Andrews NC. Forging a field: the golden age of iron biology. Blood. 2008;112:219–30.

    Article  CAS  Google Scholar 

  16. Lynch S, Pfeiffer CM, Georgieff MK, Brittenham G, Fairweather-Tait S, Hurrell RF, et al. Biomarkers of nutrition for development (BOND)—iron review. J Nutrition. 2018;148:1001S-1067S.

    Article  Google Scholar 

  17. Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition. 2010;26:1031–7.

    Article  CAS  Google Scholar 

  18. Malinowski SS. Nutritional and metabolic complications of bariatric surgery. Am J Medical Sci. 2006;331:219–25.

    Article  Google Scholar 

  19. Antoine D, Li Z, Quilliot D, Sirveaux M-A, Meyre D, Mangeon A, et al. Medium term post-bariatric surgery deficit of vitamin B12 is predicted by deficit at time of surgery. Clin Nutr. 2021;40:87–93.

    Article  CAS  Google Scholar 

  20. Li Z, Gueant-Rodriguez R-M, Quilliot D, Sirveaux M-A, Meyre D, Gueant J-L, et al. Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity. Clin Nutr. 2018;37:1700–6.

    Article  CAS  Google Scholar 

  21. Guan B, Chen Y, Chong TH, Peng J, Mak TK, Wang C, et al. Effect of bariatric surgery on serum enzyme status in obese patients. Obes Surg. 2020;30:2700–7.

    Article  Google Scholar 

  22. Burza MA, Romeo S, Kotronen A, Svensson P-A, Sjöholm K, Torgerson JS, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. Plos One. 2013;8:e60495.

    Article  CAS  Google Scholar 

  23. Ledoux S, Sami O, Calabrese D, Gall ML, Flamant M, Coupaye M. Gastric bypass specifically impairs liver parameters as compared with sleeve gastrectomy, independently of evolution of metabolic disorders. Surg Obes Relat Dis. 2019;15:220–6.

    Article  Google Scholar 

  24. Lassailly G, Caiazzo R, Ntandja-Wandji L-C, Gnemmi V, Baud G, Verkindt H, et al. Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis. Gastroenterology. 2020;159:1290-1301.e5.

    Article  Google Scholar 

  25. Wu J, You J, Yerian L, Shiba A, Schauer PR, Sessler DI. Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients. Obes Surg. 2012;22:240–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fernando M. A. Giuffrida.

Ethics declarations

Statement of Informed Consent

Since this is a retrospective study of medical records, no formal consent was required.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key Points

• Iron deficiency is a common complication after Roux-en-Y gastric bypass (RYGB), but hepatic steatosis can falsely elevate ferritin levels.

• Ferritin levels were lower after RYGB, but significantly higher in individuals with established steatosis.

• Mild anemia was seen in all individuals postoperatively, but no interaction with steatosis was demonstrated.

• No apparent implication of this finding was seen in the prescription of iron replacement therapy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

da Costa Leite Junior, G., Lacerda, M.D., Alencar, T.A.L.B. et al. Behavior of Iron and Ferritin After Bariatric Surgery in Patients With and Without Hepatic Steatosis. OBES SURG 31, 4761–4766 (2021). https://doi.org/10.1007/s11695-021-05629-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-021-05629-x

Keywords

Navigation